Evidence map›Paper›PMID 19685247›Full record

ArticleHuman genetics2009

Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulators.

Gaia Gestri, Robert J Osborne, Alexander W Wyatt, Dianne Gerrelli, Susan Gribble, Helen Stewart, Alan Fryer, David J Bunyan, Katrina Prescott, J Richard O Collin and 5 more

Abstract read
In one paragraph

Article in Human genetics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. DNA-based eyelid trait prediction in Chinese Han population.International journal of legal medicine · 2021
    Article
  13. Review
  14. Early Embryonic Expression ofJournal of cardiovascular development and disease · 2020
    Article
  15. Chemical-induced craniofacial anomalies caused by disruption of neural crest cell development in a zebrafish model.Developmental dynamics : an official publication of the American Association of Anatomists · 2020
    Article
  16. Article
  17. A Heterozygous Novel Mutation inFrontiers in pediatrics · 2020
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Gaia GestriDepartment of Cell and Developmental Biology, UCL, London, UK.
Robert J Osborne
Alexander W Wyatt
Dianne Gerrelli
Susan Gribble
Helen Stewart
Alan Fryer
David J Bunyan
Katrina Prescott
J Richard O Collin
Tomas Fitzgerald
David Robinson
Nigel P Carter
Stephen W Wilson
Nicola K Ragge
University of Oxford · GBWellcome Sanger Institute · GBSalisbury University · USUniversity College London · GBChapel Allerton Hospital · GBInstitute of Child Health · INJohn Radcliffe Hospital · GBMoorfields Eye Hospital NHS Foundation Trust · GBUniversity of Liverpool · GB

Funding

Medical Research Council G0501487Medical Research Council G0700089Medical Research Council G9900837Wellcome Trust 074376Wellcome Trust 078047Wellcome Trust WT077008
6 · The paper itself

Abstract

Mutations in the transcription factor encoding TFAP2A gene underlie branchio-oculo-facial syndrome (BOFS), a rare dominant disorder characterized by distinctive craniofacial, ocular, ectodermal and renal anomalies. To elucidate the range of ocular phenotypes caused by mutations in TFAP2A, we took three approaches. First, we screened a cohort of 37 highly selected individuals with severe ocular anomalies plus variable defects associated with BOFS for mutations or deletions in TFAP2A. We identified one individual with a de novo TFAP2A four amino acid deletion, a second individual with two non-synonymous variations in an alternative splice isoform TFAP2A2, and a sibling-pair with a paternally inherited whole gene deletion with variable phenotypic expression. Second, we determined that TFAP2A is expressed in the lens, neural retina, nasal process, and epithelial lining of the oral cavity and palatal shelves of human and mouse embryos--sites consistent with the phenotype observed in patients with BOFS. Third, we used zebrafish to examine how partial abrogation of the fish ortholog of TFAP2A affects the penetrance and expressivity of ocular phenotypes due to mutations in genes encoding bmp4 or tcf7l1a. In both cases, we observed synthetic, enhanced ocular phenotypes including coloboma and anophthalmia when tfap2a is knocked down in embryos with bmp4 or tcf7l1a mutations. These results reveal that mutations in TFAP2A are associated with a wide range of eye phenotypes and that hypomorphic tfap2a mutations can increase the risk of developmental defects arising from mutations at other loci.

Indexed as

AdultAnimalsBranchio-Oto-Renal SyndromeChild, PreschoolEyeEye AbnormalitiesFemaleGene DeletionHumansInfantMaleMiddle AgedMorphogenesisMutationRetinaTranscription Factor AP-2TFAP2A protein, humantfap2a protein, zebrafishTranscription Factor AP-2Zebrafish Proteins

Identifiers

PMID19685247
PMCPMC3083835
OpenAlexW2058702127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.